7-127595945-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020369.3(FSCN3):c.783C>A(p.His261Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000194 in 1,591,706 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020369.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FSCN3 | NM_020369.3 | c.783C>A | p.His261Gln | missense_variant | 2/7 | ENST00000265825.6 | NP_065102.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FSCN3 | ENST00000265825.6 | c.783C>A | p.His261Gln | missense_variant | 2/7 | 1 | NM_020369.3 | ENSP00000265825 | P1 | |
FSCN3 | ENST00000478821.1 | c.381C>A | p.His127Gln | missense_variant | 2/3 | 5 | ENSP00000473531 | |||
FSCN3 | ENST00000469242.1 | n.505C>A | non_coding_transcript_exon_variant | 1/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152242Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000185 AC: 42AN: 227382Hom.: 0 AF XY: 0.000247 AC XY: 30AN XY: 121656
GnomAD4 exome AF: 0.000196 AC: 282AN: 1439464Hom.: 0 Cov.: 33 AF XY: 0.000220 AC XY: 157AN XY: 713752
GnomAD4 genome AF: 0.000171 AC: 26AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2023 | The c.783C>A (p.H261Q) alteration is located in exon 2 (coding exon 2) of the FSCN3 gene. This alteration results from a C to A substitution at nucleotide position 783, causing the histidine (H) at amino acid position 261 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at